𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The pharmacokinetics of fluconazole during haemodialysis in uraemic patients

✍ Scribed by S. Oono; K. Tabei; T. Tetsuka; Y. Asano


Publisher
Springer
Year
1992
Tongue
English
Weight
199 KB
Volume
42
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

✦ Synopsis


We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5)% (n = 4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2)% (n = 5) and 39 (2.2)% (n = 9) respectively. The estimated amount extracted by a dialysis of 4 h was 33 (3.2)% (n = 4) of the dose. During repeated administration the serum fluconazole concentration increased, reaching a plateau at about 4 times the peak concentration after the first dose. After discontinuing administration the serum fluconazole concentration fell by 25% in every 3 h dialysis session. We conclude that fluconazole should be given in the usual dose of 100 or 200 mg at the end of every haemodialysis session.


πŸ“œ SIMILAR VOLUMES


Haemodialysis of pyrazinamide in uraemic
✍ C. Lacroix; A. Hermelin; R. Guiberteau; C. Guyonnaud; J. Nouveau; H. Duwoos; O. πŸ“‚ Article πŸ“… 1989 πŸ› Springer 🌐 English βš– 310 KB
The pharmacokinetics and pharmacodynamic
✍ T. W. B. Gehr; D. A. Sica; D. M. Grasela; K. L. Duchin πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 662 KB

The pharmacokinetics and pharmacodynamics of fosinoprilat, the diacid of fosinopril sodium (a new angiotensin-converting enzyme (ACE) inhibitor), were investigated in six haemodialysis patients. Intravenous 14C-fosinoprilat (7.5 mg), oral 14C-fosinopril sodium (10 mg) and oral fosinopril sodium (10

Pharmacokinetics and dialysability of is
✍ K. SchΓΆnholzer; C. Marone πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 258 KB

The pharmacokinetics of isradipine, a calcium-channel blocker, have been studied in eight patients on chronic haemodialysis. A single oral dose of 5 mg was administered on both a non-haemodialysis and a haemodialysis day and the plasma concentrations of isradipine were analyzed. The mean cmax, tmax,